Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jard

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Advances in Experimental Medicine and Biology|January 1, 1995
Identification of agonist binding sites of vasopressin and oxytocin receptorsB Mouillac, B Chini, M N Balestre, et al.
The EMBO Journal|May 15, 1995
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptorB Chini, B Mouillac, Y Ala, et al.
FEBS Letters|November 18, 1996
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressinB Chini, B Mouillac, M N Balestre, et al.
Neuroendocrinology|August 1, 1995
Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptorsC Barbeis, M N Balestre, S Jard, et al.
European Journal of Pharmacology|July 23, 1997
Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptorsY Ala, D Morin, E Mahé, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotypeY Ala, D Morin, B Mouillac, et al.
The Journal of Clinical Investigation|December 15, 1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonistC Serradeil-Le Gal, C Lacour, G Valette, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Advances in Experimental Medicine and Biology|January 1, 1995
Identification of agonist binding sites of vasopressin and oxytocin receptorsB Mouillac, B Chini, M N Balestre, et al.
The EMBO Journal|May 15, 1995
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptorB Chini, B Mouillac, Y Ala, et al.
FEBS Letters|November 18, 1996
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressinB Chini, B Mouillac, M N Balestre, et al.
Neuroendocrinology|August 1, 1995
Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptorsC Barbeis, M N Balestre, S Jard, et al.
European Journal of Pharmacology|July 23, 1997
Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptorsY Ala, D Morin, E Mahé, et al.
Journal of the American Society of Nephrology : JASN|October 17, 1998
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotypeY Ala, D Morin, B Mouillac, et al.
The Journal of Clinical Investigation|December 15, 1996
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonistC Serradeil-Le Gal, C Lacour, G Valette, et al.
Pageof 7